BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16020993)

  • 1. Use of famotidine in adult patients with end-stage renal disease: assessment of dosing and mental status changes.
    Redmond AM; Pentapaty N; Weibel J; Nolan SF; Hudson JQ; Self T
    Am J Med Sci; 2005 Jul; 330(1):8-10. PubMed ID: 16020993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system reactions associated with famotidine: report of five cases.
    Odeh M; Oliven A
    J Clin Gastroenterol; 1998 Oct; 27(3):253-4. PubMed ID: 9802455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famotidine-associated mental status changes.
    Rodgers PT; Brengel GR
    Pharmacotherapy; 1998; 18(2):404-7. PubMed ID: 9545163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.
    Kim J; Ogai A; Nakatani S; Hashimura K; Kanzaki H; Komamura K; Asakura M; Asanuma H; Kitamura S; Tomoike H; Kitakaze M
    J Am Coll Cardiol; 2006 Oct; 48(7):1378-84. PubMed ID: 17010798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
    Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
    J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
    Vasil'ev IuV; Li IA
    Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect and safety of famotidine for therapy of gastrointestinal bleeding in children].
    Chen FB; Huang XL; Chen J; Wu M; Wang J; Zhou X
    Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):64-5. PubMed ID: 15796817
    [No Abstract]   [Full Text] [Related]  

  • 8. Famotidine-associated delirium. A series of six cases.
    Catalano G; Catalano MC; Alberts VA
    Psychosomatics; 1996; 37(4):349-55. PubMed ID: 8701013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual erythemas with eosinophilia, caused by H2-blocker famotidine in a male patient with glioblastoma.
    Horiuchi Y; Bae SJ; Katayama I; Hayashi Y
    J Dermatol; 2004 Jul; 31(7):577-9. PubMed ID: 15492426
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of famotidine in infants.
    Wenning LA; Murphy MG; James LP; Blumer JL; Marshall JD; Baier J; Scheimann AO; Panebianco DL; Zhong L; Eisenhandler R; Yeh KC; Kearns GL
    Clin Pharmacokinet; 2005; 44(4):395-406. PubMed ID: 15828852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cholestatic hepatitis in a child treated with famotidine.
    Jiménez-Sáenz M; Argüelles-Arias F; Herrerías-Gutiérrez JM; Durán-Quintana JA
    Am J Gastroenterol; 2000 Dec; 95(12):3665-6. PubMed ID: 11151926
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy.
    Kallal SM; Lee M
    West J Med; 1996 May; 164(5):446-8. PubMed ID: 8686308
    [No Abstract]   [Full Text] [Related]  

  • 13. The tolerability and safety profile of famotidine.
    Howden CW; Tytgat GN
    Clin Ther; 1996; 18(1):36-54; discussion 35. PubMed ID: 8851452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare Case of Famotidine-Induced Delirium in a Peritoneal Dialysis Patient.
    Chan GC; Lee KM; Kwan LP; Mok MM; Ma MK; Yap DY; Tang SC
    Perit Dial Int; 2017 1-2; 37(1):118-120. PubMed ID: 28153970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral famotidine: a potential treatment for children with autism.
    Linday LA
    Med Hypotheses; 1997 May; 48(5):381-6. PubMed ID: 9185122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
    Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
    N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.
    von Einsiedel RW; Roesch-Ely D; Diebold K; Sartor K; Mundt C; Bergemann N
    Pharmacopsychiatry; 2002 Jul; 35(4):152-4. PubMed ID: 12163986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prolonged effect of midazolam with delayed postanesthetic recovery from the possible interference of famotidine].
    Barrau P; Giannelloni C; Gindre G; Bérard JP; Bazin JE
    Ann Fr Anesth Reanim; 1998; 17(5):361-4. PubMed ID: 9750765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute duodenal ulcers with famotidine and its comparison with other H2 blockers.
    Akhtar MA; Rashid P; Khan MA
    J Pak Med Assoc; 1990 Jun; 40(6):136-7. PubMed ID: 1975277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.
    Deutsch SI; Rosse RB; Kendrick KA; Fay-McCarthy M; Collins JP; Wyatt RJ
    Clin Neuropharmacol; 1993 Dec; 16(6):518-24. PubMed ID: 9377587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.